Where it comes from
- Made in
- N cells of the ileum; neurons in the hypothalamus, brainstem and reward pathways
- Sent out by
- Fat in the gut above all; in the brain, alongside dopamine
- Acts on
- Gut (motility and fat absorption)
- Dopamine neurons
- Hypothalamus
What it does
In medicine
- No medicine. Pro-neurotensin in blood predicted new diabetes, cardiovascular disease, breast cancer and death in a large Swedish cohort 1, and has since been linked with fatty liver and stroke in others
- NTSR1 is over-expressed in pancreatic and other cancers and is the target of experimental radioligands 3
Beyond the body’s own use
- NTSR1 agonists are studied as antipsychotics and as non-opioid analgesics in animals. None has reached a trial in people, because activating the receptor also drops blood pressure and body temperature 2
- A lutetium-177 NTSR1 radioligand has been given to a handful of people with metastatic pancreatic cancer, with tumour shrinkage in some and no approval 3
- Pro-neurotensin is a research measure, not a clinical test: the association with later disease is consistent but nobody has shown that changing neurotensin changes the risk 1
Sources
- Melander et al., Plasma proneurotensin and incidence of diabetes, cardiovascular disease, breast cancer and mortality, JAMA 2012
- Thompson et al., Influence of the neurotensin signalling system on feeding and satiety, Neuropharmacology 2025
- Baum et al., Lutetium-177-3BP-227 for neurotensin receptor 1-targeted therapy of metastatic pancreatic adenocarcinoma, Journal of Nuclear Medicine 2018
This card describes what a medicine is for and what the evidence says; it recommends nothing. Talk to your clinician about anything you read here.